Vigeo Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 11
- Market Cap
- -
Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Vigeo Therapeutics, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT03364400
- Locations
- 🇺🇸
Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath